In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Lars Soendergaard
Speaker
Lars Soendergaard
Lars Soendergaard Lars Soendergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Specialities : Interventional Cardiology , Congenital Heart Disease and Pediatric Cardiology

Graduate in 1988 from University of Copenhagen. Trained in cardiology at Rigshospitalet in Copenhagen, as well as Great Ormond Street Hospital for Sick Children and The Heart Hospital in London. Special interest in congenital and structural heart diseases, particular interventional procedures, and Head of these programs at Rigshospitalet in Copenhagen. Led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012. Professor of Cardiology at University of Copenhagen. Published 338 peer reviewed articles, and 16 text book chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. Lead principal investigator for several trials including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

17 presentations from this speaker

Antithrombotic treatment after valve replacement.

Event : ESC Congress 2020

  • Session : Valvular Heart Disease - Essential Update
  • Speaker : L Soendergaard (Hilleroed,DK)

Complex case during COVID-19: improving procedural effectiveness with remote proctoring.

Event : ESC Congress 2020

  • Session : Challenges and learnings in Cardiovascular Care through the COVID 19 crisis
  • Speaker : L Soendergaard (Hilleroed,DK)
  • Sponsored by ABBOTT

Left Atrial Appendage Closure.

Event : ESC Congress 2020

  • Session : Left Atrial Appendage Closure
  • Speaker : L Soendergaard (Hilleroed,DK), A Tzikas (Thessaloniki,GR), O De Backer (Copenhagen,DK)

Aortic valve disease – Extending indications for TAVI.

Event : ESC Congress 2019

  • Session : The European Heart Journal’s advances in heart failure and valvular heart disease
  • Speaker : L Soendergaard (Hilleroed,DK)
  • Joint with the European Heart Journal

Management of patients with asymptomatic leaflet hypoattenuation on CT

Event : ESC Congress 2019

  • Session : Transcatheter treatment of valvular heart disease: stretching the limits
  • Speaker : L Soendergaard (Hilleroed,DK)

Tips and tricks for a successful TAVI procedure.

Event : ESC Congress 2019

  • Session : TAVI - Transcatheter Aortic Valve Implantation
  • Speaker : L Soendergaard (Hilleroed,DK)

Transcatheter vs. surgical treatment of mitral regurgitation.

Event : Webinar 2019

  • Session : ESC Webinars 2019
  • Speaker : G Dreyfus (Paris,FR), C Grasso (Catania,IT), L Soendergaard (Hilleroed,DK)

Identification of structural valve deterioration by imaging.

Event : ESC Congress 2018

  • Session : Valve durability after transcatheter and surgical aortic valve replacement
  • Speaker : L Soendergaard (Hilleroed,DK)

PFO closure for cryptogenic stroke – Represented in NEJM by the CLOSURE I, PC, REDUCE, CLOSE, and RESPECT trials

Event : ESC Congress 2018

  • Session : Highlights from the New England Journal of Medicine: Editors’ Choice
  • Speaker : L Soendergaard (Hilleroed,DK)
  • Organised with the New England Journal of Medicine

TAVI for patients with congenital heart disease: a reasonable option?

Event : ESC Congress 2018

  • Session : Interventional treatment of valve disease in congenital heart disease patients
  • Speaker : L Soendergaard (Hilleroed,DK)

Transcatheter valvular intervention: established and emerging treatment options

Event : ESC Congress 2018

  • Session : Congress Condensed Valvular Heart Disease
  • Speaker : L Soendergaard (Hilleroed,DK)

CT to assess TAVR thombosis.

Event : ESC Congress 2017

  • Session : Image Interpretation with the Masters - Thrombosis of bioprosthetic heart valves
  • Speaker : L Soendergaard (Hilleroed,DK)

All we need are antiplatelet agents – CON

Event : ESC Congress 2016

  • Session : Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?
  • Speaker : L Soendergaard (Hilleroed,DK)

Progress with new generation devices

Event : ESC Congress 2016

  • Session : Update on transcatheter aortic valve implantation in 2016
  • Speaker : L Soendergaard (Hilleroed,DK)

Interventional therapy.

Event : ESC Congress 2013

  • Session : Management of pulmonary hypertension due to congenital heart disease
  • Speaker : L Soendergaard (Hilleroed,DK)

Percutaneous valves: where do they fit in the future?

Event : ESC Congress 2013

  • Session : Valve and coronary disease across continents: India and Europe
  • Speaker : L Soendergaard (Hilleroed,DK)

Transcutaneous mitral valve replacement: possibilites and barriers.

Event : ESC Congress 2013

  • Session : Update on percutaneous mitral valve options
  • Speaker : L Soendergaard (Hilleroed,DK)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are